Cognitive-behavioral issues in the treatment and management of chronic daily headache.
Chronic daily headache is a heterogeneous group of daily or near-daily headaches that afflicts close to 5% of the general population and accounts for close to 35% to 40% of patients at headache centers. First-line drug or cognitive-behavioral therapies administered alone have minimal impact on reducing the frequency or severity of headaches. However, combined drug and cognitive-behavioral therapy shows promise in providing the most benefit for this often intractable condition. Cognitive-behavioral therapies focus on preventing mild pain from becoming disabling pain, improving headache-related disability, affective distress, and quality of life, and reducing overreliance on medication. For cognitive-behavioral therapies to be effective, it is important to address complicating factors, including medication overuse, psychiatric comorbidity, stress and poor coping, and sleep disturbance.
Lipchik
Gay L
GL
St. Vincent Rehabilitation Services, 3413 Cherry Street, Erie, PA 16508, USA. Glipchik@aol.com
Nash
Justin M
JM
D000639:Amitriptyline / Q000627:therapeutic use; D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use; D001676:Biofeedback, Psychology; D002908:Chronic Disease; D015928:Cognitive Behavioral Therapy / Q000379:methods*; D003131:Combined Modality Therapy; D006261:Headache / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D010507:Periodicity; D012064:Relaxation Therapy
D018712:Analgesics, Non-Narcotic; D000639:Amitriptyline